| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | vesicle cargo loading | 6.83e-07 | 36 | 40 | 4 | GO:0035459 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 3.56e-06 | 339 | 40 | 7 | GO:0048193 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.35e-05 | 159 | 40 | 5 | GO:0006888 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.90e-05 | 43 | 40 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | secretion | DAB2 CTAGE15 PTPN23 SCN11A CTAGE6 SYT2 MIA2 SLC26A6 CTAGE1 VPS13A | 8.43e-05 | 1221 | 40 | 10 | GO:0046903 |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 1.31e-04 | 9 | 40 | 2 | GO:2000643 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.61e-04 | 1064 | 40 | 9 | GO:0032940 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.99e-04 | 11 | 40 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | epithelial fluid transport | 2.39e-04 | 12 | 40 | 2 | GO:0042045 | |
| GeneOntologyBiologicalProcess | export from cell | 2.93e-04 | 1153 | 40 | 9 | GO:0140352 | |
| GeneOntologyBiologicalProcess | protein secretion | 3.02e-04 | 480 | 40 | 6 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 3.12e-04 | 483 | 40 | 6 | GO:0035592 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.29e-04 | 14 | 40 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 3.37e-04 | 490 | 40 | 6 | GO:0071692 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.35e-06 | 42 | 41 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cuticular plate | 2.89e-04 | 13 | 41 | 2 | GO:0032437 | |
| Domain | Spectrin | 1.23e-05 | 23 | 37 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 2.52e-05 | 29 | 37 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.41e-05 | 32 | 37 | 3 | IPR018159 | |
| Domain | SPEC | 3.41e-05 | 32 | 37 | 3 | SM00150 | |
| Domain | EF-hand_1 | 2.26e-04 | 152 | 37 | 4 | PF00036 | |
| Domain | EF-hand_7 | 6.32e-04 | 85 | 37 | 3 | PF13499 | |
| Domain | Actinin_actin-bd_CS | 9.41e-04 | 23 | 37 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 9.41e-04 | 23 | 37 | 2 | PS00020 | |
| Domain | ACTININ_1 | 9.41e-04 | 23 | 37 | 2 | PS00019 | |
| Domain | EF_HAND_2 | 1.09e-03 | 231 | 37 | 4 | PS50222 | |
| Domain | EF_hand_dom | 1.11e-03 | 232 | 37 | 4 | IPR002048 | |
| Domain | - | 1.71e-03 | 261 | 37 | 4 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 2.42e-03 | 287 | 37 | 4 | IPR011992 | |
| Domain | EFh | 3.74e-03 | 158 | 37 | 3 | SM00054 | |
| Domain | EF_Hand_1_Ca_BS | 4.97e-03 | 175 | 37 | 3 | IPR018247 | |
| Domain | CH | 7.34e-03 | 65 | 37 | 2 | SM00033 | |
| Domain | EF_HAND_1 | 7.59e-03 | 204 | 37 | 3 | PS00018 | |
| Domain | CH | 8.47e-03 | 70 | 37 | 2 | PF00307 | |
| Domain | - | 8.71e-03 | 71 | 37 | 2 | 1.10.418.10 | |
| Domain | CH | 9.19e-03 | 73 | 37 | 2 | PS50021 | |
| Domain | SH3_domain | 9.33e-03 | 220 | 37 | 3 | IPR001452 | |
| Domain | CH-domain | 9.68e-03 | 75 | 37 | 2 | IPR001715 | |
| Pubmed | FAM169A CTAGE15 MACF1 SCN11A CTAGE6 ATM MIA2 NLRP7 CTAGE1 SYNE2 CCDC158 VPS13A | 6.37e-08 | 1442 | 41 | 12 | 35575683 | |
| Pubmed | 4.31e-07 | 13 | 41 | 3 | 33963279 | ||
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 6.85e-07 | 15 | 41 | 3 | 30224460 | |
| Pubmed | Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. | 1.36e-06 | 2 | 41 | 2 | 11050238 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32423230 | ||
| Pubmed | Parvalbumin Interneurons Determine Emotional Valence Through Modulating Accumbal Output Pathways. | 1.36e-06 | 2 | 41 | 2 | 31139063 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18297277 | ||
| Pubmed | Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef. | 1.36e-06 | 2 | 41 | 2 | 24180678 | |
| Pubmed | 3.03e-06 | 24 | 41 | 3 | 35790771 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29130968 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22226504 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20691752 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 10771338 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30545133 | ||
| Pubmed | Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. | 4.06e-06 | 3 | 41 | 2 | 10716718 | |
| Pubmed | EF-hand protein Ca2+ buffers regulate Ca2+ influx and exocytosis in sensory hair cells. | 4.06e-06 | 3 | 41 | 2 | 25691754 | |
| Pubmed | Cerebellar network plasticity: from genes to fast oscillation. | 4.06e-06 | 3 | 41 | 2 | 18359574 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30578652 | ||
| Pubmed | Region- and Cell-Specific Expression of Transmembrane Collagens in Mouse Brain. | 4.06e-06 | 3 | 41 | 2 | 28912695 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8153091 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26081613 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28521135 | ||
| Pubmed | 5.44e-06 | 29 | 41 | 3 | 32123907 | ||
| Pubmed | 6.72e-06 | 225 | 41 | 5 | 12168954 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 27619726 | ||
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 8.12e-06 | 4 | 41 | 2 | 27311593 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 31244610 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21807889 | ||
| Pubmed | A circuit of mossy cells controls the efficacy of memory retrieval by Gria2I inhibition of Gria2. | 8.12e-06 | 4 | 41 | 2 | 33596426 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 22272358 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12115690 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 8.12e-06 | 4 | 41 | 2 | 33718348 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12586826 | ||
| Pubmed | Dlx1 and Dlx2 Promote Interneuron GABA Synthesis, Synaptogenesis, and Dendritogenesis. | 8.12e-06 | 4 | 41 | 2 | 29028947 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 11827796 | ||
| Pubmed | A Sensorimotor Circuit in Mouse Cortex for Visual Flow Predictions. | 8.12e-06 | 4 | 41 | 2 | 28910624 | |
| Pubmed | 1.06e-05 | 36 | 41 | 3 | 33230114 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19074032 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 1.35e-05 | 5 | 41 | 2 | 12839582 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15558732 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 12150774 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 38926335 | ||
| Pubmed | Distribution and development of molecularly distinct perineuronal nets in visual thalamus. | 1.35e-05 | 5 | 41 | 2 | 30326149 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 23912123 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 8359228 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 7516699 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 18630941 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19131326 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 1.35e-05 | 5 | 41 | 2 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 1.35e-05 | 5 | 41 | 2 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 1.35e-05 | 5 | 41 | 2 | 21183079 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 30523065 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 28842412 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 23894587 | ||
| Pubmed | Cortical hypoplasia and ventriculomegaly of p73-deficient mice: Developmental and adult analysis. | 1.35e-05 | 5 | 41 | 2 | 24500610 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 33589589 | ||
| Pubmed | Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. | 2.03e-05 | 6 | 41 | 2 | 29440485 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 36568982 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 8809809 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 29380551 | ||
| Pubmed | Ultraconserved Enhancers Are Required for Normal Development. | 2.03e-05 | 6 | 41 | 2 | 29358049 | |
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 2.03e-05 | 6 | 41 | 2 | 9733643 | |
| Pubmed | Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. | 2.03e-05 | 6 | 41 | 2 | 23091025 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 29716957 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 19288186 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 31282864 | ||
| Pubmed | Learning-Related Plasticity in Dendrite-Targeting Layer 1 Interneurons. | 2.84e-05 | 7 | 41 | 2 | 30269988 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 9735355 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 34616071 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 28985566 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 22710612 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 17376969 | ||
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 2.84e-05 | 7 | 41 | 2 | 29133483 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 15813942 | ||
| Pubmed | Oncomodulin identifies different hair cell types in the mammalian inner ear. | 2.84e-05 | 7 | 41 | 2 | 20653034 | |
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 2.84e-05 | 7 | 41 | 2 | 15377789 | |
| Pubmed | Contactin-5 expression during development and wiring of the thalamocortical system. | 2.84e-05 | 7 | 41 | 2 | 26391921 | |
| Pubmed | Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines. | 2.84e-05 | 7 | 41 | 2 | 29869046 | |
| Pubmed | Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome. | 2.84e-05 | 7 | 41 | 2 | 26961948 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 36805633 | ||
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 2.87e-05 | 50 | 41 | 3 | 27597886 | |
| Pubmed | Meningeal defects alter the tangential migration of cortical interneurons in Foxc1hith/hith mice. | 3.78e-05 | 8 | 41 | 2 | 22248045 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 3.78e-05 | 8 | 41 | 2 | 9382709 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 8812145 | ||
| Pubmed | Site-specific and developmental expression of pannexin1 in the mouse nervous system. | 3.78e-05 | 8 | 41 | 2 | 16026466 | |
| Pubmed | Molecular correlates of muscle spindle and Golgi tendon organ afferents. | 3.78e-05 | 8 | 41 | 2 | 33649316 | |
| Pubmed | Cortical regulation of neurogenesis and cell proliferation in the ventral subventricular zone. | 3.78e-05 | 8 | 41 | 2 | 37422764 | |
| Pubmed | A cell-ECM mechanism for connecting the ipsilateral eye to the brain. | 3.78e-05 | 8 | 41 | 2 | 34654745 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 21441923 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 8725284 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 26319231 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 26718312 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 18287934 | ||
| Pubmed | 4.02e-05 | 162 | 41 | 4 | 15174051 | ||
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 4.04e-05 | 56 | 41 | 3 | 29184203 | |
| Pubmed | Cortical interneurons require p35/Cdk5 for their migration and laminar organization. | 4.86e-05 | 9 | 41 | 2 | 19037081 | |
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 15102706 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 22791192 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 8562707 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 16571605 | ||
| Interaction | CTAGE1 interactions | 2.77e-09 | 10 | 40 | 4 | int:CTAGE1 | |
| Interaction | CTAGE15 interactions | 7.22e-08 | 5 | 40 | 3 | int:CTAGE15 | |
| Interaction | CTAGE6 interactions | 1.44e-07 | 6 | 40 | 3 | int:CTAGE6 | |
| Interaction | CTAGE4 interactions | 1.15e-05 | 3 | 40 | 2 | int:CTAGE4 | |
| Interaction | CTAGE7P interactions | 5.73e-05 | 6 | 40 | 2 | int:CTAGE7P | |
| Interaction | CTAGE8 interactions | 5.73e-05 | 6 | 40 | 2 | int:CTAGE8 | |
| Interaction | MIA2 interactions | 7.33e-05 | 113 | 40 | 4 | int:MIA2 | |
| Interaction | PRMT7 interactions | 1.11e-04 | 47 | 40 | 3 | int:PRMT7 | |
| Cytoband | 7q35 | 1.12e-03 | 55 | 41 | 2 | 7q35 | |
| Cytoband | 3p21.3 | 1.29e-03 | 59 | 41 | 2 | 3p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.61e-03 | 66 | 41 | 2 | chr7q35 | |
| GeneFamily | CTAGE family | 8.30e-09 | 15 | 30 | 4 | 907 | |
| GeneFamily | EF-hand domain containing | 4.48e-04 | 219 | 30 | 4 | 863 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.92e-06 | 681 | 41 | 8 | M39175 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.60e-05 | 856 | 41 | 8 | M4500 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 5.71e-05 | 134 | 41 | 4 | M13907 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 6.22e-05 | 444 | 41 | 6 | M41713 | |
| Coexpression | TSENG_IRS1_TARGETS_DN | 6.96e-05 | 141 | 41 | 4 | MM681 | |
| Coexpression | ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON | 1.30e-04 | 11 | 41 | 2 | M39092 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.64e-04 | 176 | 41 | 4 | M39223 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.82e-04 | 181 | 41 | 4 | M39225 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 1.96e-04 | 786 | 41 | 7 | M2388 | |
| Coexpression | YAGI_AML_WITH_11Q23_REARRANGED | 1.98e-04 | 346 | 41 | 5 | M17123 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 2.05e-04 | 73 | 41 | 3 | M6939 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 2.43e-04 | 362 | 41 | 5 | M39176 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 2.47e-04 | 196 | 41 | 4 | M8135 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 2.52e-04 | 197 | 41 | 4 | M5853 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 2.62e-04 | 199 | 41 | 4 | M6646 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 2.62e-04 | 199 | 41 | 4 | M6839 | |
| Coexpression | GSE3982_MAC_VS_TH2_UP | 2.62e-04 | 199 | 41 | 4 | M5513 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN | 2.62e-04 | 199 | 41 | 4 | M4984 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN | 2.67e-04 | 200 | 41 | 4 | M4624 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN | 2.67e-04 | 200 | 41 | 4 | M8089 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN | 2.67e-04 | 200 | 41 | 4 | M8220 | |
| Coexpression | GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M9551 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 3.19e-04 | 384 | 41 | 5 | M1865 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 3.66e-04 | 871 | 41 | 7 | MM1005 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_2HR_DN | 3.67e-04 | 89 | 41 | 3 | M8916 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.90e-04 | 221 | 41 | 4 | M39222 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 3.94e-04 | 402 | 41 | 5 | MM1248 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.50e-10 | 197 | 41 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.29e-08 | 193 | 41 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-07 | 192 | 41 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.24e-05 | 155 | 41 | 4 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 171 | 41 | 4 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 180 | 41 | 4 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.28e-05 | 181 | 41 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 182 | 41 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.38e-05 | 183 | 41 | 4 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-05 | 183 | 41 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-05 | 185 | 41 | 4 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.76e-05 | 190 | 41 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.76e-05 | 190 | 41 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 190 | 41 | 4 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.76e-05 | 190 | 41 | 4 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.82e-05 | 191 | 41 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 192 | 41 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 193 | 41 | 4 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.94e-05 | 193 | 41 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-05 | 193 | 41 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 193 | 41 | 4 | 7deb439943d35a4e825674b2b7dcddb45d366ad1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 193 | 41 | 4 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.00e-05 | 194 | 41 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.00e-05 | 194 | 41 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.00e-05 | 194 | 41 | 4 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-05 | 194 | 41 | 4 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.06e-05 | 195 | 41 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 3.12e-05 | 196 | 41 | 4 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.18e-05 | 197 | 41 | 4 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.18e-05 | 197 | 41 | 4 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.18e-05 | 197 | 41 | 4 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.24e-05 | 198 | 41 | 4 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | c54da37aa11f82a68e591d563b3db9121d6b498f | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-05 | 198 | 41 | 4 | 90023468f3498548a92d75928f476b4157bde813 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.31e-05 | 199 | 41 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 3.37e-05 | 200 | 41 | 4 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.88e-04 | 121 | 41 | 3 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Lgr5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-04 | 28 | 41 | 2 | 065da9144b7d8c79a583122288f1e7b5db86a794 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.19e-04 | 145 | 41 | 3 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | Cerebellum|World / BrainAtlas - Mouse McCarroll V32 | 3.33e-04 | 147 | 41 | 3 | dd730224e39571ca2c35042e242a908a02ee377d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.60e-04 | 151 | 41 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.96e-04 | 156 | 41 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 157 | 41 | 3 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.26e-04 | 160 | 41 | 3 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 161 | 41 | 3 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.34e-04 | 161 | 41 | 3 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 161 | 41 | 3 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.42e-04 | 162 | 41 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.42e-04 | 162 | 41 | 3 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 4.58e-04 | 164 | 41 | 3 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-04 | 167 | 41 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-04 | 167 | 41 | 3 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 4.83e-04 | 167 | 41 | 3 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 4.91e-04 | 168 | 41 | 3 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 5.00e-04 | 169 | 41 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.17e-04 | 171 | 41 | 3 | d934d68efc5739483c735dc702ccd30b07a6aa7e | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.17e-04 | 171 | 41 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.17e-04 | 171 | 41 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 5.26e-04 | 172 | 41 | 3 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.35e-04 | 173 | 41 | 3 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 5.35e-04 | 173 | 41 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 173 | 41 | 3 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.44e-04 | 174 | 41 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-04 | 175 | 41 | 3 | 3c3cbaeec6ef2f61e6b177c95b999752c2d83ddb | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-04 | 175 | 41 | 3 | 2dcb5145835c3872d0f92f3ece23730cf65487bd | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.53e-04 | 175 | 41 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.62e-04 | 176 | 41 | 3 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.62e-04 | 176 | 41 | 3 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.62e-04 | 176 | 41 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.72e-04 | 177 | 41 | 3 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-04 | 177 | 41 | 3 | f7a2e6b5e82f0565f8030696944f33c544233b94 | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.72e-04 | 177 | 41 | 3 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-04 | 177 | 41 | 3 | ef02ee75db36a92dda889efb6fad1193efbc4be4 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 5.81e-04 | 178 | 41 | 3 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.99e-04 | 49 | 29 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.14e-04 | 200 | 37 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 3.48e-04 | 22 | 37 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | parental longevity | 3.61e-04 | 494 | 37 | 5 | EFO_0007796 | |
| Disease | PR interval | 3.64e-04 | 495 | 37 | 5 | EFO_0004462 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.44e-04 | 127 | 37 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | mood instability measurement | 5.56e-04 | 128 | 37 | 3 | EFO_0008475 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.48e-04 | 148 | 37 | 3 | C0279702 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 8.81e-04 | 150 | 37 | 3 | EFO_0004611, EFO_0020947 | |
| Disease | diabetic nephropathy | 8.81e-04 | 150 | 37 | 3 | EFO_0000401 | |
| Disease | Malignant neoplasm of breast | 2.03e-03 | 1074 | 37 | 6 | C0006142 | |
| Disease | Metastatic melanoma | 2.10e-03 | 54 | 37 | 2 | C0278883 | |
| Disease | platelet component distribution width | 2.39e-03 | 755 | 37 | 5 | EFO_0007984 | |
| Disease | cortical thickness | 2.43e-03 | 1113 | 37 | 6 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLDKMDGSMPSEMES | 616 | Q96RT6 | |
| KMTSLDKMDGSMPSE | 646 | Q86UF2 | |
| DKMDGSMPSEMESSR | 651 | Q86UF2 | |
| KMTSLDKMDGSMPSE | 646 | A4D2H0 | |
| DKMDGSMPSEMESSR | 651 | A4D2H0 | |
| MKMEEMSLSGLDNSK | 1 | Q14CW9 | |
| GSMDKVDMGSMKGQK | 936 | P02462 | |
| GMTTDDDAVSEMKMG | 956 | Q9UPQ7 | |
| SMLGAMDKRVSEEGM | 126 | Q9H3S7 | |
| DSMMKLKGMAAAGRS | 71 | P98082 | |
| GVGMKKMMVVDGDSG | 451 | A2RU67 | |
| GKMFTAGIDLMDMAS | 111 | Q13011 | |
| TTNEMMDDTDEKMGK | 401 | O60774 | |
| MSGDEMIFDPTMSKK | 1 | P20042 | |
| GGSMMMSEKTDEEDS | 2256 | Q9UPN3 | |
| MNAEGKSKDKGDMEV | 551 | Q7Z442 | |
| GVSEVNGMMKRDGMK | 2496 | Q13315 | |
| MLTGDMGSLDDPKMK | 1156 | Q53EP0 | |
| EMLMDEGTSDEKGHM | 496 | Q9Y6X4 | |
| MKKLKMRAGGMSDSS | 211 | Q92538 | |
| KRKQDDADQDMMMAG | 1476 | P11047 | |
| GMMSKSDNFGEKMKE | 56 | P22676 | |
| KSMEGSDGHAMKVAM | 716 | Q5M9N0 | |
| LDKMDGSMPSEMESS | 1256 | Q96PC5 | |
| MNMKDMKGGQDDDDA | 106 | Q8N9I0 | |
| MDVFMKGLSMAKEGV | 1 | Q16143 | |
| GGDMMTLLMKKDTLT | 171 | Q15208 | |
| KGSMFDELMARSEDM | 776 | Q8WXH0 | |
| EDCKMMQVSSGDKME | 626 | Q9BXS9 | |
| MMMGCGESELKSADG | 1 | Q8TAP8 | |
| TELCKMAKAEMMEDG | 81 | Q8WX94 | |
| EGTKGTMKMDMEDAD | 31 | O75626 | |
| NIDDAKDAMMAMNGK | 56 | Q14011 | |
| KDAMMAMNGKSVDGR | 61 | Q14011 | |
| GTMMKAKGDLEMKEE | 11 | Q9BTP6 | |
| GAMAKGVAAMTMDED | 2926 | Q96RL7 | |
| GMKDMELDASSMEKR | 2801 | Q15413 | |
| KETKMLMAAGDKDGD | 81 | P20472 | |
| DFEMSGNMSDDMKEI | 1096 | O94964 | |
| EAMSGMEGRKKMFDA | 166 | P19237 | |
| SGLDMGKIEEMEKML | 1141 | Q86UU1 | |
| GSDGLDSMKAMMEEK | 1696 | Q9UI33 | |
| GAPKMTEEEEKAMKM | 616 | P13866 | |
| KMDLSGGMLQDKRME | 1226 | Q8NDV7 | |
| MALMKEDGVPDDMKG | 1996 | O75962 |